Iqvia Holdings (IQV) Cash from Investing Activities (2012 - 2026)
Iqvia Holdings (IQV) posted Cash from Investing Activities of -$381.0 million for Q2 2026, down 94.39% sequentially from -$196.0 million in Q1 2026, and down 10.12% YoY from -$423.9 million in Q2 2025.
Iqvia Holdings (IQV) Cash from Investing Activities (2012 - 2026) Analysis & Trends
Iqvia Holdings has reported Cash from Investing Activities for 15 years, with the latest figure at -$381.0 million in Q2 2026.
- Quarterly Cash from Investing Activities fell 10.12% year-over-year to -$381.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$2.2 billion (down 43.01% YoY) and the FY2025 annual result came in at -$2.3 billion, down 59.63% from the prior year.
- Cash from Investing Activities eased to -$381.0 million in Q2 2026 per IQV's latest filing, from -$196.0 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at -$196.0 million in Q1 2026 and troughed at -$1.1 billion in Q4 2025.
- A 5-year average of -$440.8 million and a median of -$363.5 million in 2025 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2023 and 2025: Cash from Investing Activities surged 63.78% in 2023, then sank 256.13% in 2025.
- Over 5 years, Cash from Investing Activities stood at -$477.0 million in 2022, then surged by 55.56% to -$212.0 million in 2023, then plunged by 46.23% to -$310.0 million in 2024, then tumbled by 256.13% to -$1.1 billion in 2025, then surged by 65.49% to -$381.0 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$381.0 million, -$196.0 million, and -$1.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.99 Bn | 209.92 Bn | 8.34 Bn | 164.00 Mn |
| 2 | Danaher | 140.41 Bn | 136.06 Bn | 3.61 Bn | -10.15 Bn |
| 3 | Idexx Laboratories | 46.27 Bn | 46.08 Bn | 779.09 Mn | -25.50 Mn |
| 4 | Agilent Technologies | 39.81 Bn | 38.00 Bn | 990.00 Mn | -77.00 Mn |
| 5 | Iqvia Holdings | 39.53 Bn | 37.45 Bn | 1.44 Bn | -381.00 Mn |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn | -32.14 Mn |
| 7 | Illumina | 30.03 Bn | 28.86 Bn | 770.00 Mn | -122.00 Mn |
| 8 | Mettler Toledo International | 28.67 Bn | 28.62 Bn | 650.22 Mn | -1.94 Mn |
| 9 | Quest Diagnostics | 26.16 Bn | 25.54 Bn | 1.03 Bn | -134.00 Mn |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn | -322.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -381.00 Mn |
| Jun 30, 2026 | -381.00 Mn |
| Mar 31, 2026 | -196.00 Mn |
| Mar 31, 2026 | -196.00 Mn |
| Dec 31, 2025 | -1.10 Bn |
| Dec 31, 2025 | -1.10 Bn |
| Sep 30, 2025 | -550.00 Mn |
| Sep 30, 2025 | -550.00 Mn |
| Jun 30, 2025 | -346.00 Mn |
| Jun 30, 2025 | -346.00 Mn |
| Mar 31, 2025 | -305.00 Mn |
| Mar 31, 2025 | -305.00 Mn |
| Dec 31, 2024 | -310.00 Mn |
| Dec 31, 2024 | -310.00 Mn |
| Sep 30, 2024 | -599.00 Mn |
| Sep 30, 2024 | -599.00 Mn |
| Jun 30, 2024 | -221.00 Mn |
| Jun 30, 2024 | -221.00 Mn |
| Mar 31, 2024 | -314.00 Mn |
| Mar 31, 2024 | -314.00 Mn |